Perceived efficacy of hydroxychloroquine in observational studies: Results of the confounding effect of "goals of care".
作者信息
Tleyjeh Prof Imad M, Tlayjeh Haytham
机构信息
Infectious Diseases Section, Department of Medical Specialties King Fahad Medical City, Riyadh, Saudi Arabia; Division of Infectious Diseases, Mayo Clinic College of Medicine and Science, Rochester, MN, USA; Department of Epidemiology, Mayo Clinic College of Medicine and Science, Rochester, MN, USA; College of Medicine, Al Faisal University, Riyadh, Saudi Arabia.
Department of Intensive Care, King Abdulaziz Medical City, Riyadh, Saudi Arabia.
出版信息
Int J Antimicrob Agents. 2021 Apr;57(4):106308. doi: 10.1016/j.ijantimicag.2021.106308. Epub 2021 Feb 17.
Abstract
摘要
相似文献
1
Perceived efficacy of hydroxychloroquine in observational studies: Results of the confounding effect of "goals of care".观察性研究中羟氯喹的感知疗效：“治疗目标”混杂效应的结果
Int J Antimicrob Agents. 2021 Apr;57(4):106308. doi: 10.1016/j.ijantimicag.2021.106308. Epub 2021 Feb 17.
2
Shining a light on the evidence for hydroxychloroquine in SARS-CoV-2.揭示羟氯喹在新型冠状病毒肺炎中的证据
Crit Care. 2020 Apr 28;24(1):182. doi: 10.1186/s13054-020-02894-7.
3
Hydroxychloroquine or Chloroquine for Treatment or Prophylaxis of COVID-19: A Living Systematic Review.羟氯喹或氯喹治疗或预防 COVID-19：一项实时系统评价。
Ann Intern Med. 2020 Aug 18;173(4):287-296. doi: 10.7326/M20-2496. Epub 2020 May 27.
4
Hydroxychloroquine as Prophylaxis for Coronavirus SARS-CoV-2 Infection: Review of the Ongoing Clinical Trials.羟氯喹作为新型冠状病毒SARS-CoV-2感染的预防用药：正在进行的临床试验综述
Arch Bronconeumol (Engl Ed). 2020 Sep;56(9):606-608. doi: 10.1016/j.arbr.2020.05.010. Epub 2020 Sep 14.
5
Aminoquinolines against coronavirus disease 2019 (COVID-19): chloroquine or hydroxychloroquine.抗2019冠状病毒病（COVID-19）的氨基喹啉：氯喹或羟氯喹。
Int J Antimicrob Agents. 2020 Apr;55(4):105945. doi: 10.1016/j.ijantimicag.2020.105945. Epub 2020 Mar 17.
6
Norwegian Coronavirus Disease 2019 (NO COVID-19) Pragmatic Open label Study to assess early use of hydroxychloroquine sulphate in moderately severe hospitalised patients with coronavirus disease 2019: A structured summary of a study protocol for a randomised controlled trial.挪威 2019 年冠状病毒病（NO COVID-19）实用开放性标签研究，评估硫酸羟氯喹在 2019 年冠状病毒病中度重症住院患者中的早期使用：一项随机对照试验研究方案的结构化总结。
Trials. 2020 Jun 5;21(1):485. doi: 10.1186/s13063-020-04420-0.
7
Interpreting the impact of hydroxychloroquine prophylaxis on SARS-CoV-2 infection.解读羟氯喹预防对严重急性呼吸综合征冠状病毒2感染的影响。
Indian J Med Res. 2021 May;153(5&6):564-565. doi: 10.4103/ijmr.ijmr_1092_21.
8
A pragmatic randomized controlled trial reports lack of efficacy of hydroxychloroquine on coronavirus disease 2019 viral kinetics.一项实用随机对照试验报告称羟氯喹对 2019 年冠状病毒病病毒动力学无效。
Nat Commun. 2020 Oct 20;11(1):5284. doi: 10.1038/s41467-020-19056-6.
9
Use of hydroxychloroquine to prevent SARS-CoV-2 infection and treat mild COVID-19: a systematic review and meta-analysis.使用羟氯喹预防 SARS-CoV-2 感染和治疗轻症 COVID-19：系统评价和荟萃分析。
J Bras Pneumol. 2021 Oct 15;47(5):e20210236. doi: 10.36416/1806-3756/e20210236. eCollection 2021.
10
Hydroxychloroquine in Hospitalized Patients with Covid-19.新冠肺炎住院患者使用羟氯喹的情况
N Engl J Med. 2021 Mar 4;384(9):881-882. doi: 10.1056/NEJMc2035374. Epub 2021 Feb 10.
引用本文的文献
1
Overlooked Shortcomings of Observational Studies of Interventions in Coronavirus Disease 2019: An Illustrated Review for the Clinician.2019年冠状病毒病干预措施观察性研究被忽视的缺点：给临床医生的图文综述
Open Forum Infect Dis. 2021 Jul 1;8(8):ofab317. doi: 10.1093/ofid/ofab317. eCollection 2021 Aug.
2
Reply to "The perceived efficacy of hydroxychloroquine in observational studies: the results of the confounding effects of 'goals of care'".对《观察性研究中羟氯喹的感知疗效：“治疗目标”的混杂效应结果》的回复
Int J Antimicrob Agents. 2021 Apr;57(4):106307. doi: 10.1016/j.ijantimicag.2021.106307. Epub 2021 Feb 17.
本文引用的文献
1
It is time to drop hydroxychloroquine from our COVID-19 armamentarium.是时候从我们的 COVID-19 武器库中淘汰羟氯喹了。
Med Hypotheses. 2020 Nov;144:110198. doi: 10.1016/j.mehy.2020.110198. Epub 2020 Aug 17.
2
Low-dose hydroxychloroquine therapy and mortality in hospitalised patients with COVID-19: a nationwide observational study of 8075 participants.低剂量羟氯喹治疗对 COVID-19 住院患者死亡率的影响：一项全国性观察研究，纳入 8075 名参与者。
Int J Antimicrob Agents. 2020 Oct;56(4):106144. doi: 10.1016/j.ijantimicag.2020.106144. Epub 2020 Aug 24.
3
Ethics guidelines on COVID-19 triage-an emerging international consensus.关于新冠病毒分诊的伦理准则——一种新出现的国际共识
Crit Care. 2020 May 6;24(1):201. doi: 10.1186/s13054-020-02927-1.
4
Accounting for Patient Preferences Regarding Life-Sustaining Treatment in Evaluations of Medical Effectiveness and Quality.在医学有效性和质量评估中考虑患者对维持生命治疗的偏好。
Am J Respir Crit Care Med. 2017 Oct 15;196(8):958-963. doi: 10.1164/rccm.201701-0165CP.
5
Conclusion about the association between valve surgery and mortality in an infective endocarditis cohort changed after adjusting for survivor bias.瓣膜手术后感染性心内膜炎患者死亡率的相关结论在调整幸存者偏差后发生了变化。
J Clin Epidemiol. 2010 Feb;63(2):130-5. doi: 10.1016/j.jclinepi.2008.06.022.
Zotero 插件